Setting the Record Straight on Biosimilar Interchangeability

Patients should understand that biosimilars are fully vetted through a vigorous, lengthy FDA review process, and offer the same clinical benefits and effectiveness of the originator biologic. Still, much confusion exists about interchangeability, especially with Senate Bill S. 2840 working its way through Congress.